Skip to Main content Skip to Navigation
Journal articles

Pathology of peripheral T-cell lymphomas: where do we stand?

Abstract : Peripheral T-cell lymphomas (PTCLs) are heterogeneous and uncommon malignancies characterized by a usually aggressive clinical course. The current World Health Organization (WHO) classification delineates many entities grouped according to the clinical presentation as predominantly leukemic, cutaneous, extranodal, or nodal diseases. Yet, few genetic lesions serve as entity-defining markers. Using high-throughput methods, new recurrent genetic and molecular alterations are being discovered that are expected to refine the current classification and serve as diagnostic genetic markers and targets for novel therapies. There is increasing evidence that certain cellular subsets, in particular follicular helper T cells and gamma delta T cells, represent important defining markers and/or determinants of the biology of certain entities; nevertheless, the cellular derivation of many PTCL entities remains poorly characterized and there is evidence of plasticity in terms of cellular derivation (alpha-beta, gamma-delta, natural killer [NK]) especially in several extranodal entities with a cytotoxic profile. While most clonal NK/T-cell proliferations are in general highly malignant, some more indolent forms of NK or T-cell lympho-proliferations are being identified.
Document type :
Journal articles
Complete list of metadatas

Cited literature [38 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00957335
Contributor : Georges Guellaen <>
Submitted on : Monday, March 10, 2014 - 11:18:54 AM
Last modification on : Wednesday, August 19, 2020 - 11:17:02 AM
Long-term archiving on: : Sunday, April 9, 2017 - 10:16:51 PM

Files

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Philippe Gaulard, Laurence de Leval. Pathology of peripheral T-cell lymphomas: where do we stand?. Seminars in Hematology, WB Saunders, 2014, 51 (1), pp.5-16. ⟨10.1053/j.seminhematol.2013.11.003⟩. ⟨inserm-00957335⟩

Share

Metrics

Record views

249